Table II.
Advanced lipid status profile, adipocytokines and oxidative stress parameters in analyzed groups.
| Parameter | CKD patients (n=19) | PT patients (n=19) | P |
|---|---|---|---|
| LDL particle size (nm) | 25.96±1.96 | 26.22±1.30 | 0.636 |
| sdLDL (%) | 50.62±5.41 | 49.42±4.10 | 0.448 |
| HDL particle size (nm) | 9.48±1.04 | 10.59±0.80 | 0.001 |
| HDL 2b (%) | 39.28±5.43 | 48.64±4.85 | <0.001 |
| HDL 2a (%) | 21.27±2.13 | 22.58±2.28 | 0.077 |
| HDL 3a (%) | 16.77±2.60 | 14.00±2.19 | <0.001 |
| HDL 3b (%) | 10.14±2.13 | 7.52±1.53 | <0.001 |
| HDL 3c (%) | 12.56±6.52 | 7.17±1.49 | 0.002 |
| Leptin (pg/mL)* | 4.40 (2.00–11.90) | 5.10 (2.10–27.90) | 0.644 |
| Adiponectin (g/mL) | 26.92±14.13 | 18.01±11.31 | 0.048 |
| SH-groups (g/L) | 0.46±0.10 | 0.52±0.06 | 0.026 |
| O2- (mmol/min/L) | 203.43±65.16 | 187.23±51.39 | 0.401 |
| AOPP (mmol/L) * | 25.13 (18.32–31.39) | 20.26 (15.83–27.62) | 0.216 |
| SOD (kU/L) | 105.48± 38.11 | 93.85±12.91 | 0.221 |
| POase (U/L) * | 224.1 (183.33–346.29) | 346.3 (142.59–570.36) | 0.148 |
| TBARS (mmol/L) | 1.72±0.36 | 1.58±0.41 | 0.271 |
| MPO (mg/L)* | 138.05 (54.25–192.26) | 61.69 (34.58–135.74) | 0.086 |
| MPO/PON1 ratio* | 0.57 (0.21–0.76) | 0.15 (0.07–0.60) | 0.032 |
Data are expressed as mean ± SD and compared by Student-t test
*Values are expressed as medians and interquartile ranges and compared by Mann-Whitney U-test